Overview

Model evaluation quantifies how well a predictive model will perform on unseen data — the core measure of its practical utility. In bioinformatics, where models guide clinical decisions, prioritize experiments, or generate biological hypotheses, rigorous evaluation is essential to avoid overoptimistic claims and irreproducible results. The fundamental challenge is that performance measured on the training data is an inflated estimate of true generalization ability; proper evaluation protocols simulate the prediction of truly new data.

Methods

Cross-validation partitions the data into complementary subsets, training on most and evaluating on the held-out fold. K-fold cross-validation repeats this process K times, providing a robust performance estimate with reduced variance. Stratified cross-validation preserves class proportions in each fold and is critical for imbalanced datasets. Leave-one-out cross-validation is appropriate for very small sample sizes but has high variance. Bootstrapping resamples the data with replacement to estimate confidence intervals around performance metrics. Common classification metrics include accuracy, precision, recall, F1-score, and the area under the receiver operating characteristic curve (AUROC). For regression, mean squared error and R-squared are standard. Statistical tests such as the McNemar test compare whether two models have significantly different performance.

Applications

Rigorous evaluation is vital when models are used to diagnose disease from DNA microarrays and gene expression profiles, predict patient outcomes in cancer biochemistry, or classify bacterial strains in bacterial genetics. In each case, proper validation ensures that reported performance reflects genuine predictive signal rather than artifacts of data leakage, batch effects, or overfitting, supporting reliable translation to clinical or laboratory use.